Journal article
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis
Abstract
INTRODUCTION: We aimed to evaluate the real-world effectiveness and safety of tofacitinib for the treatment of ulcerative colitis (UC).
METHODS: REMIT-UC is a Canadian multicenter cohort study. Standardized data collection was performed on 334 consecutive adult outpatients with UC treated with tofacitinib. The primary outcomes were achievement of clinical and endoscopic remission. Safety outcomes were reported using incidence rates (events/100 …
Authors
Ma C; Panaccione R; Xiao Y; Khandelwal Y; Murthy SK; Wong ECL; Narula N; Tsai C; Peerani F; Reise-Filteau M
Journal
The American Journal of Gastroenterology, Vol. 118, No. 5, pp. 861–871
Publisher
Wolters Kluwer
Publication Date
May 2023
DOI
10.14309/ajg.0000000000002129
ISSN
0002-9270